253 related articles for article (PubMed ID: 9790231)
1. Serum insulin-like growth factor II in 44 patients with non-islet cell tumor hypoglycemia.
Hizuka N; Fukuda I; Takano K; Okubo Y; Asakawa-Yasumoto K; Demura H
Endocr J; 1998 Apr; 45 Suppl():S61-5. PubMed ID: 9790231
[TBL] [Abstract][Full Text] [Related]
2. Serum high molecular weight form of insulin-like growth factor II from patients with non-islet cell tumor hypoglycemia is O-glycosylated.
Hizuka N; Fukuda I; Takano K; Asakawa-Yasumoto K; Okubo Y; Demura H
J Clin Endocrinol Metab; 1998 Aug; 83(8):2875-7. PubMed ID: 9709962
[TBL] [Abstract][Full Text] [Related]
3. Levels of glucose-regulatory hormones in patients with non-islet cell tumor hypoglycemia: including a review of the literature.
Fukuda I; Asai A; Nagamine T; Harada T; Tanimura-Inagaki K; Hizuka N; Sugihara H
Endocr J; 2017 Jul; 64(7):719-726. PubMed ID: 28529277
[TBL] [Abstract][Full Text] [Related]
4. Serum "big insulin-like growth factor II" from patients with tumor hypoglycemia lacks normal E-domain O-linked glycosylation, a possible determinant of normal propeptide processing.
Daughaday WH; Trivedi B; Baxter RC
Proc Natl Acad Sci U S A; 1993 Jun; 90(12):5823-7. PubMed ID: 7685912
[TBL] [Abstract][Full Text] [Related]
5. Characterization of insulin-like growth factor II (IGF-II) and IGF binding proteins in patients with non-islet-cell tumor hypoglycemia.
Fukuda I; Hizuka N; Takano K; Asakawa-Yasumoto K; Shizume K; Demura H
Endocr J; 1993 Feb; 40(1):111-9. PubMed ID: 7524924
[TBL] [Abstract][Full Text] [Related]
6. Increased levels of circulating free insulin-like growth factors in patients with non-islet cell tumour hypoglycaemia.
Frystyk J; Skjaerbaek C; Zapf J; Orskov H
Diabetologia; 1998 May; 41(5):589-94. PubMed ID: 9628278
[TBL] [Abstract][Full Text] [Related]
7. Measurement of derivatives of proinsulin-like growth factor-II in serum by a radioimmunoassay directed against the E-domain in normal subjects and patients with nonislet cell tumor hypoglycemia.
Daughaday WH; Trivedi B
J Clin Endocrinol Metab; 1992 Jul; 75(1):110-5. PubMed ID: 1618998
[TBL] [Abstract][Full Text] [Related]
8. Clinical features of insulin-like growth factor-II producing non-islet-cell tumor hypoglycemia.
Fukuda I; Hizuka N; Ishikawa Y; Yasumoto K; Murakami Y; Sata A; Morita J; Kurimoto M; Okubo Y; Takano K
Growth Horm IGF Res; 2006 Aug; 16(4):211-6. PubMed ID: 16860583
[TBL] [Abstract][Full Text] [Related]
9. A rapid method for analyzing serum pro-insulin-like growth factor-II in patients with non-islet cell tumor hypoglycemia.
Miraki-Moud F; Grossman AB; Besser M; Monson JP; Camacho-Hübner C
J Clin Endocrinol Metab; 2005 Jul; 90(7):3819-23. PubMed ID: 15840753
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic potential of miR-483 family for IGF-II producing non-islet cell tumor hypoglycemia.
Nagao M; Fukuda I; Asai A; Esguerra JLS; Hizuka N; Eliasson L; Sugihara H
Eur J Endocrinol; 2021 Jan; 184(1):41-49. PubMed ID: 33112286
[TBL] [Abstract][Full Text] [Related]
11. Antibodies directed against the E region of pro-insulin-like growth factor-II used to evaluate non-islet cell tumor-induced hypoglycemia.
van Doorn J; Hoogerbrugge CM; Koster JG; Bloemen RJ; Hoekman K; Mudde AH; van Buul-Offers SC
Clin Chem; 2002 Oct; 48(10):1739-50. PubMed ID: 12324491
[TBL] [Abstract][Full Text] [Related]
12. Glucocorticoid therapy suppresses abnormal secretion of big IGF-II by non-islet cell tumours inducing hypoglycaemia (NICTH).
Teale JD; Marks V
Clin Endocrinol (Oxf); 1998 Oct; 49(4):491-8. PubMed ID: 9876347
[TBL] [Abstract][Full Text] [Related]
13. Severe hypoglycemia with "Big"-IGF-2 oversecretion by a giant phyllode tumor of the breast: a rare case of non-islet cell tumor-induced hypoglycemia (NICTH).
Renard E; Langbour-Remy C; Klein M; Le Bouc Y; Weryha G; Cuny T
Ann Endocrinol (Paris); 2012 Nov; 73(5):488-91. PubMed ID: 22867750
[TBL] [Abstract][Full Text] [Related]
14. [Hypoglycemia associated with the production of insulin-like growth factor (IGF)-II by a hemangiopericytoma].
Plikat K; Reichle A; Elmlinger MW; Schölmerich J
Dtsch Med Wochenschr; 2003 Feb; 128(6):257-60. PubMed ID: 12571793
[TBL] [Abstract][Full Text] [Related]
15. Significance of abnormal serum binding of insulin-like growth factor II in the development of hypoglycemia in patients with non-islet-cell tumors.
Daughaday WH; Kapadia M
Proc Natl Acad Sci U S A; 1989 Sep; 86(17):6778-82. PubMed ID: 2771956
[TBL] [Abstract][Full Text] [Related]
16. Study of serum big-insulin-like growth factor (IGF)-II and IGF binding proteins in two patients with extrapancreatic tumor hypoglycemia, using a combination of Western blotting methods.
Christofilis MA; Remacle-Bonnet M; Atlan-Gepner C; Garrouste F; Vialettes B; Fuentes P; Guidicelli R; Pommier G
Eur J Endocrinol; 1998 Sep; 139(3):317-22. PubMed ID: 9758443
[TBL] [Abstract][Full Text] [Related]
17. Quantitative analysis of the concentrations of IGFs and several IGF-binding proteins in a large fibrous abdominal tumor and the circulation of a patient with hypoglycemia.
van Doorn J; van de Hoef W; Dullaart RP
Biofactors; 2015 May; 41(3):183-9. PubMed ID: 26073062
[TBL] [Abstract][Full Text] [Related]
18. The effectiveness of different treatment options for non-islet cell tumour hypoglycaemia.
Teale JD; Wark G
Clin Endocrinol (Oxf); 2004 Apr; 60(4):457-60. PubMed ID: 15049960
[TBL] [Abstract][Full Text] [Related]
19. A case of a giant phyllodes tumor of the breast with hypoglycemia caused by high-molecular-weight insulin-like growth factor II.
Hino N; Nakagawa Y; Ikushima Y; Yoshida M; Tsuyuguchi M
Breast Cancer; 2010 Apr; 17(2):142-5. PubMed ID: 19259766
[TBL] [Abstract][Full Text] [Related]
20. Big insulin-like growth factor 2-producing multiple solitary fibrous tumors treated with debulking surgery: A case report.
Keidai Y; Murakami T; Yamamura N; Tsunoda S; Ikeda A; Hida K; Nagao M; Yamada Y; Fukui A; Ogura M; Fukuda I; Nakamoto Y; Obama K; Inagaki N
Front Endocrinol (Lausanne); 2023; 14():1071899. PubMed ID: 36742395
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
